.After antibody-drug conjugate (ADC) specialist Seagen was actually sold to Pfizer in 2013 for a tre...
.On the heels of a phase 3 gain that stopped working to excite investors, Ironwood Pharmaceuticals i...
.Don't cease Monte Rosa Therapies now. The Boston-based biotech is enjoying after authorizing a deal...
.Welcome to today's Chutes & Ladders, our summary of notable leadership hirings, firings and also...
.Commemorating his company's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the open...
.AbbVie has actually gone back to the source of its antipsychotic giant Vraylar trying to find anoth...
.GenSight Biologics is actually weeks off of lacking cash. Once more. The biotech only has enough ca...
.Monopar Rehabs is recouping a drug from the scrap heap of AstraZeneca's unusual illness pipeline. I...
.With brand-new records out on Arcus Biosciences' speculative HIF-2a inhibitor, one group of analyst...
.After creating a genetics treatment relationship with Dyno Rehabs in 2020, Roche is actually back f...